Denali Therapeutics (DNLI)
Develops brain-penetrating therapies and commercializes AVLAYAH for Hunter syndrome.
$20.62
vs last close−0.98 (−4.54%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 98.52% | 157.48M shares | |
|---|---|---|---|
| 302 holders · as of Jun 30, 2026 | |||
| Insiders | 7.04% | 11.26M shares | |
| 13 holders · as of Sep 9, 2026 | |||
| Adds to | 105.56% | ||
159.85M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
These groups come from separate filings that can overlap, so they add to 105.56%; nothing is left for Other.
13F, as of Jun 30, 2026
302 holders · 157.48M shares · 57 new positions · 179 increased · 69 reduced · 31 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 16.18M | 10.12% | +7.66M | Aug 14, 2026 |
| BlackRock, Inc. | 14.03M | 8.77% | +992.0K | Aug 7, 2026 |
| Baillie Gifford & Co | 11.96M | 7.48% | −106.2K | Aug 6, 2026 |
| State Street Corp | 7.05M | 4.41% | +777.3K | Aug 7, 2026 |
| Temasek Holdings (Private) Ltd | 7.01M | 4.39% | 0 | Aug 7, 2026 |
| Vanguard Portfolio Management LLC | 6.48M | 4.05% | +356.9K | Aug 13, 2026 |
| Vanguard Capital Management LLC | 6.28M | 3.93% | +127.8K | Aug 13, 2026 |
| FMR LLC | 4.54M | 2.84% | −39.5K | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Baillie Gifford & Co | 8.60% | 12.31M | 13G | Feb 12, 2025 |
| BlackRock, Inc. | 7.20% | 10.49M | 13G | Apr 17, 2025 |
| T. Rowe Price Investment Management, Inc. | 5.40% | 8.52M | 13G | May 15, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 4, 2026 | Peter Scott Chinofficer: Chief Medical Officer | Sale | 1,654 | $22.29 | 204,538 |
| Sep 2, 2026 | Nancy Thornberrydirector | Sale · 2 lots | 11,439 | $22.90 | 19,686 |
| Sep 1, 2026 | Alexander O. Schuthofficer: COFO and Secretary | Sale | 2,768 | $23.44 | 278,995 |
| Aug 11, 2026 | Alexander O. Schuthofficer: COFO and Secretary | Sale | 2,857 | $25.07 | 281,763 |
| Jan 6, 2026 | Alexander O. Schuthofficer: COFO and Secretary | Sale | 17,218 | $16.50 | 282,828 |
| Jan 6, 2026 | Ryan J. Wattsdirector, officer: President and CEO | Sale | 35,198 | $16.50 | 296,833 |
| Dec 11, 2025 | Baker Bros. Advisors LPdirector | Purchase · 2 lots | 2,285,714 | $0.0100 | 25,996,310 |
House and Senate disclosures
Not reported.